Page last updated: 2024-10-30

leflunomide and Graft Occlusion, Vascular

leflunomide has been researched along with Graft Occlusion, Vascular in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morris, RE1
Huang, X1
Gregory, CR1
Billingham, ME1
Rowan, R1
Shorthouse, R1
Berry, GJ1

Other Studies

1 other study available for leflunomide and Graft Occlusion, Vascular

ArticleYear
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Transplantation proceedings, 1995, Volume: 27, Issue:3

    Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Occlusion, Vascular; Heart Transplantation; I

1995